nodes	percent_of_prediction	percent_of_DWPC	metapath
Aspartame—Nateglinide—type 2 diabetes mellitus	0.306	0.622	CrCtD
Aspartame—Ramipril—type 2 diabetes mellitus	0.186	0.378	CrCtD
Aspartame—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.0627	0.186	CrCrCtD
Aspartame—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0332	0.276	CbGbCtD
Aspartame—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0296	0.246	CbGbCtD
Aspartame—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0251	0.209	CbGbCtD
Aspartame—Mitiglinide—Nateglinide—type 2 diabetes mellitus	0.0239	0.0708	CrCrCtD
Aspartame—Lisinopril—Nateglinide—type 2 diabetes mellitus	0.0207	0.0612	CrCrCtD
Aspartame—Spirapril—Nateglinide—type 2 diabetes mellitus	0.0207	0.0612	CrCrCtD
Aspartame—Ramipril—Nateglinide—type 2 diabetes mellitus	0.0194	0.0574	CrCrCtD
Aspartame—Enalapril—Nateglinide—type 2 diabetes mellitus	0.0194	0.0574	CrCrCtD
Aspartame—Trandolapril—Nateglinide—type 2 diabetes mellitus	0.0194	0.0574	CrCrCtD
Aspartame—SLC22A6—Glyburide—type 2 diabetes mellitus	0.017	0.141	CbGbCtD
Aspartame—Lacosamide—Nateglinide—type 2 diabetes mellitus	0.0164	0.0486	CrCrCtD
Aspartame—SLC22A6—Losartan—type 2 diabetes mellitus	0.0155	0.129	CbGbCtD
Aspartame—Mitiglinide—Ramipril—type 2 diabetes mellitus	0.0146	0.0431	CrCrCtD
Aspartame—Lisinopril—Ramipril—type 2 diabetes mellitus	0.0126	0.0372	CrCrCtD
Aspartame—Spirapril—Ramipril—type 2 diabetes mellitus	0.0126	0.0372	CrCrCtD
Aspartame—Trandolapril—Ramipril—type 2 diabetes mellitus	0.0118	0.0349	CrCrCtD
Aspartame—Enalapril—Ramipril—type 2 diabetes mellitus	0.0118	0.0349	CrCrCtD
Aspartame—Phenacemide—Nateglinide—type 2 diabetes mellitus	0.0111	0.033	CrCrCtD
Aspartame—Dextroamphetamine—Nateglinide—type 2 diabetes mellitus	0.0108	0.032	CrCrCtD
Aspartame—Amphetamine—Nateglinide—type 2 diabetes mellitus	0.0108	0.032	CrCrCtD
Aspartame—Nateglinide—Ramipril—type 2 diabetes mellitus	0.0105	0.0311	CrCrCtD
Aspartame—Methamphetamine—Nateglinide—type 2 diabetes mellitus	0.0105	0.0311	CrCrCtD
Aspartame—Quinapril—Ramipril—type 2 diabetes mellitus	0.00999	0.0296	CrCrCtD
Aspartame—TRPV1—sciatic nerve—type 2 diabetes mellitus	0.00944	0.438	CbGeAlD
Aspartame—L-Phenylalanine—Nateglinide—type 2 diabetes mellitus	0.00823	0.0243	CrCrCtD
Aspartame—TRPV1—peripheral nervous system—type 2 diabetes mellitus	0.00362	0.168	CbGeAlD
Aspartame—TRPV1—nerve—type 2 diabetes mellitus	0.00282	0.131	CbGeAlD
Aspartame—TRPV1—pancreas—type 2 diabetes mellitus	0.000961	0.0445	CbGeAlD
Aspartame—SLC22A11—nephron tubule—type 2 diabetes mellitus	0.000718	0.0333	CbGeAlD
Aspartame—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000676	0.0314	CbGeAlD
Aspartame—SLC22A11—kidney—type 2 diabetes mellitus	0.000631	0.0293	CbGeAlD
Aspartame—SLC22A11—cortex of kidney—type 2 diabetes mellitus	0.000614	0.0285	CbGeAlD
Aspartame—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.000579	0.0268	CbGeAlD
Aspartame—SLC22A8—nephron tubule—type 2 diabetes mellitus	0.000405	0.0188	CbGeAlD
Aspartame—SLC22A11—liver—type 2 diabetes mellitus	0.000399	0.0185	CbGeAlD
Aspartame—Amphetamine—CARTPT—type 2 diabetes mellitus	0.000365	0.162	CrCbGaD
Aspartame—SLC22A8—kidney—type 2 diabetes mellitus	0.000356	0.0165	CbGeAlD
Aspartame—SLC22A8—cortex of kidney—type 2 diabetes mellitus	0.000347	0.0161	CbGeAlD
Aspartame—Mitiglinide—ABCC8—type 2 diabetes mellitus	0.000307	0.137	CrCbGaD
Aspartame—Mitiglinide—KCNJ11—type 2 diabetes mellitus	0.000216	0.0962	CrCbGaD
Aspartame—Nateglinide—ABCC8—type 2 diabetes mellitus	0.000156	0.0695	CrCbGaD
Aspartame—Spirapril—ACE—type 2 diabetes mellitus	0.000126	0.0558	CrCbGaD
Aspartame—Mitiglinide—PPARG—type 2 diabetes mellitus	0.00012	0.0533	CrCbGaD
Aspartame—Quinapril—ACE—type 2 diabetes mellitus	0.000112	0.0497	CrCbGaD
Aspartame—Lisinopril—ACE—type 2 diabetes mellitus	0.000112	0.0497	CrCbGaD
Aspartame—Nateglinide—KCNJ11—type 2 diabetes mellitus	0.00011	0.049	CrCbGaD
Aspartame—Trandolapril—ACE—type 2 diabetes mellitus	0.000108	0.0482	CrCbGaD
Aspartame—Ramipril—ACE—type 2 diabetes mellitus	0.000108	0.0482	CrCbGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	8.67e-05	0.00341	CbGpPWpGaD
Aspartame—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	8.54e-05	0.00336	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—IAPP—type 2 diabetes mellitus	8.52e-05	0.00336	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	8.32e-05	0.00328	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	8.27e-05	0.00326	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	8.23e-05	0.00324	CbGpPWpGaD
Aspartame—Enalapril—ACE—type 2 diabetes mellitus	8.21e-05	0.0365	CrCbGaD
Aspartame—TAS1R2—Signaling Pathways—MC4R—type 2 diabetes mellitus	8.07e-05	0.00318	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	7.95e-05	0.00313	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	7.92e-05	0.00312	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GIP—type 2 diabetes mellitus	7.76e-05	0.00306	CbGpPWpGaD
Aspartame—Bortezomib—CYP1A2—type 2 diabetes mellitus	7.75e-05	0.0344	CrCbGaD
Aspartame—TAS1R2—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	7.69e-05	0.00303	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	7.62e-05	0.003	CbGpPWpGaD
Aspartame—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	7.6e-05	0.00299	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	7.59e-05	0.00299	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	7.49e-05	0.00295	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	7.48e-05	0.00295	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—LEPR—type 2 diabetes mellitus	7.38e-05	0.0029	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	7.33e-05	0.00288	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	7.32e-05	0.00288	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—GHRL—type 2 diabetes mellitus	7.29e-05	0.00287	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	7.24e-05	0.00285	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CALCA—type 2 diabetes mellitus	7.2e-05	0.00284	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—CCL2—type 2 diabetes mellitus	7.18e-05	0.00283	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	7.07e-05	0.00278	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	7.05e-05	0.00278	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TLE4—type 2 diabetes mellitus	6.86e-05	0.0027	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	6.84e-05	0.00269	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	6.8e-05	0.00268	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—GCG—type 2 diabetes mellitus	6.67e-05	0.00263	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	6.62e-05	0.0026	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	6.6e-05	0.0026	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	6.56e-05	0.00258	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	6.38e-05	0.00251	CbGpPWpGaD
Aspartame—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	6.34e-05	0.0025	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	6.32e-05	0.00249	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	6.32e-05	0.00249	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	6.16e-05	0.00243	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	6.13e-05	0.00241	CbGpPWpGaD
Aspartame—Nateglinide—PPARG—type 2 diabetes mellitus	6.11e-05	0.0271	CrCbGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	6.1e-05	0.0024	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	6.09e-05	0.0024	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	5.98e-05	0.00236	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	5.9e-05	0.00232	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	5.88e-05	0.00232	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	5.83e-05	0.0023	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	5.83e-05	0.0023	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	5.82e-05	0.00229	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	5.78e-05	0.00228	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	5.78e-05	0.00227	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	5.78e-05	0.00227	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	5.75e-05	0.00226	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	5.71e-05	0.00225	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RBP4—type 2 diabetes mellitus	5.68e-05	0.00224	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	5.68e-05	0.00224	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	5.68e-05	0.00224	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	5.68e-05	0.00224	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AVP—type 2 diabetes mellitus	5.67e-05	0.00223	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	5.67e-05	0.00223	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	5.59e-05	0.0022	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	5.59e-05	0.0022	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	5.39e-05	0.00212	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	5.37e-05	0.00211	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	5.28e-05	0.00208	CbGpPWpGaD
Aspartame—Bortezomib—CYP3A4—type 2 diabetes mellitus	5.13e-05	0.0228	CrCbGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	5.12e-05	0.00202	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	5.12e-05	0.00202	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	5.07e-05	0.00199	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IAPP—type 2 diabetes mellitus	5.03e-05	0.00198	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—INSR—type 2 diabetes mellitus	5e-05	0.00197	CbGpPWpGaD
Aspartame—Methamphetamine—ADRA2A—type 2 diabetes mellitus	4.93e-05	0.0219	CrCbGaD
Aspartame—TAS1R2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	4.92e-05	0.00194	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	4.91e-05	0.00193	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	4.91e-05	0.00193	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	4.89e-05	0.00192	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	4.83e-05	0.0019	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	4.82e-05	0.0019	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	4.72e-05	0.00186	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—C3—type 2 diabetes mellitus	4.71e-05	0.00185	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	4.71e-05	0.00185	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	4.71e-05	0.00185	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	4.68e-05	0.00184	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	4.66e-05	0.00184	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	4.65e-05	0.00183	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	4.56e-05	0.0018	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	4.54e-05	0.00179	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	4.54e-05	0.00179	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	4.53e-05	0.00178	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	4.53e-05	0.00178	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	4.53e-05	0.00178	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AGT—type 2 diabetes mellitus	4.48e-05	0.00176	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	4.45e-05	0.00175	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	4.44e-05	0.00175	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	4.42e-05	0.00174	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	4.41e-05	0.00173	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	4.41e-05	0.00173	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	4.4e-05	0.00173	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CYBA—type 2 diabetes mellitus	4.4e-05	0.00173	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	4.33e-05	0.00171	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	4.32e-05	0.0017	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PLAT—type 2 diabetes mellitus	4.31e-05	0.0017	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GHRL—type 2 diabetes mellitus	4.31e-05	0.0017	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CALCA—type 2 diabetes mellitus	4.25e-05	0.00167	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	4.23e-05	0.00167	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	4.21e-05	0.00166	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	4.18e-05	0.00164	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	4.14e-05	0.00163	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	4.12e-05	0.00162	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	4.04e-05	0.00159	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	4.03e-05	0.00159	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.01e-05	0.00158	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GCG—type 2 diabetes mellitus	3.94e-05	0.00155	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.94e-05	0.00155	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	3.88e-05	0.00153	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.88e-05	0.00153	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.86e-05	0.00152	CbGpPWpGaD
Aspartame—Enalapril—CYP3A4—type 2 diabetes mellitus	3.86e-05	0.0171	CrCbGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	3.85e-05	0.00152	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	3.85e-05	0.00152	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	3.81e-05	0.0015	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.77e-05	0.00149	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	3.72e-05	0.00147	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	3.7e-05	0.00146	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.69e-05	0.00145	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	3.68e-05	0.00145	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	3.68e-05	0.00145	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.62e-05	0.00143	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	3.62e-05	0.00142	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	3.6e-05	0.00142	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	3.59e-05	0.00141	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	3.59e-05	0.00141	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	3.57e-05	0.00141	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	3.46e-05	0.00136	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	3.46e-05	0.00136	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	3.45e-05	0.00136	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.43e-05	0.00135	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.4e-05	0.00134	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	3.4e-05	0.00134	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.4e-05	0.00134	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	3.36e-05	0.00132	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.35e-05	0.00132	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AVP—type 2 diabetes mellitus	3.35e-05	0.00132	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.33e-05	0.00131	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.32e-05	0.00131	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.29e-05	0.00129	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—APOB—type 2 diabetes mellitus	3.24e-05	0.00127	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.22e-05	0.00127	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.19e-05	0.00126	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.19e-05	0.00125	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	3.14e-05	0.00124	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	3.1e-05	0.00122	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—LPL—type 2 diabetes mellitus	3.09e-05	0.00122	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.03e-05	0.00119	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	3e-05	0.00118	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	3e-05	0.00118	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	3e-05	0.00118	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	2.96e-05	0.00116	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	2.96e-05	0.00116	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	2.94e-05	0.00116	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	2.93e-05	0.00116	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.9e-05	0.00114	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	2.89e-05	0.00114	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.89e-05	0.00114	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.89e-05	0.00114	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.88e-05	0.00113	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	2.87e-05	0.00113	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	2.85e-05	0.00112	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.85e-05	0.00112	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	2.84e-05	0.00112	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	2.83e-05	0.00112	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—C3—type 2 diabetes mellitus	2.78e-05	0.0011	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	2.72e-05	0.00107	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.65e-05	0.00105	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.65e-05	0.00104	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AGT—type 2 diabetes mellitus	2.64e-05	0.00104	CbGpPWpGaD
Aspartame—Nateglinide—CYP3A4—type 2 diabetes mellitus	2.63e-05	0.0117	CrCbGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	2.62e-05	0.00103	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.6e-05	0.00102	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—LEP—type 2 diabetes mellitus	2.59e-05	0.00102	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—APOE—type 2 diabetes mellitus	2.59e-05	0.00102	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.56e-05	0.00101	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.53e-05	0.000996	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	2.51e-05	0.00099	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	2.45e-05	0.000966	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	2.45e-05	0.000964	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.44e-05	0.000962	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	2.4e-05	0.000944	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	2.37e-05	0.000933	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	2.36e-05	0.00093	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	2.33e-05	0.000918	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.31e-05	0.00091	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	2.3e-05	0.000905	CbGpPWpGaD
Aspartame—Nateglinide—ALB—type 2 diabetes mellitus	2.3e-05	0.0102	CrCbGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	2.27e-05	0.000894	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	2.26e-05	0.000888	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	2.26e-05	0.000888	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—INS—type 2 diabetes mellitus	2.21e-05	0.000871	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	2.2e-05	0.000867	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	2.19e-05	0.000862	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.18e-05	0.000857	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	2.18e-05	0.000857	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.14e-05	0.000843	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.14e-05	0.000842	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.13e-05	0.000839	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.03e-05	0.0008	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.98e-05	0.00078	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.97e-05	0.000777	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.97e-05	0.000776	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.96e-05	0.00077	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.94e-05	0.000764	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.94e-05	0.000764	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.92e-05	0.000755	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.89e-05	0.000744	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.88e-05	0.000741	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.88e-05	0.000741	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.84e-05	0.000723	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.83e-05	0.00072	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.83e-05	0.000719	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.83e-05	0.000719	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.82e-05	0.000715	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.78e-05	0.0007	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.77e-05	0.000696	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.75e-05	0.000691	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.65e-05	0.000649	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.64e-05	0.000645	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.6e-05	0.00063	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.59e-05	0.000628	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.56e-05	0.000613	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.54e-05	0.000607	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.53e-05	0.000601	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.51e-05	0.000595	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.51e-05	0.000595	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.5e-05	0.000592	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.5e-05	0.000589	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.49e-05	0.000587	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.48e-05	0.000584	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.46e-05	0.000576	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.44e-05	0.000568	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.44e-05	0.000565	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.4e-05	0.000551	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.35e-05	0.00053	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.28e-05	0.000505	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.26e-05	0.000497	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.26e-05	0.000495	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.26e-05	0.000494	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.24e-05	0.00049	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.22e-05	0.000479	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.2e-05	0.000474	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.18e-05	0.000466	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.14e-05	0.000449	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.12e-05	0.000443	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.01e-05	0.000399	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IL6—type 2 diabetes mellitus	9.67e-06	0.000381	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	9.52e-06	0.000375	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	9.04e-06	0.000356	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.92e-06	0.000351	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	7.54e-06	0.000297	CbGpPWpGaD
